JPRN-jRCT2080222071未知2 期
Phase II/III Study of S-877503 in Pediatric Patients with Attention-deficit/Hyperactivity Disorder -Long term Extension Study
适应症
试验速览
- 阶段
- 2 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patient has completed 9-week administration and the last examination at Visit 9 in the preceding study of S-877503 in pediatric patients with ADHD. And et al.
排除标准
- •1) Patient has complications such as serious hepatic disorder, renal disorder, heart disease,
- •lung disease, hematological disease, and metabolic disease.
- •2) Patient considered a suicide risk. And et al.
研究者
相似试验
未知
2 期
Phase II/III Study of S-877503 in Pediatric Patients with Attention-deficit/Hyperactivity DisorderJPRN-jRCT2080222070SHIONOGI & CO., LTD.
招募中
3 期
A Phase 3 study of S-217622 in pediatric participantsSARS-CoV-2 infectionJPRN-jRCT2031230140Gomez Juan Carlos120
未知
3 期
Phase 3 Clinical Study of S-4661 in pediatric patients with meningitis and other bacterial infectionsJPRN-jRCT2080221492SHIONOGI & CO., LTD.
已完成
2 期
Phase II/III Study of S-877489 in Pediatric Patients with Attention-deficit/Hyperactivity DisorderAttention-deficit/Hyperactivity DisorderJPRN-jRCT2080222718Shionogi & Co., Ltd.76
招募中
3 期
A phase 3 study of S-812217 in patients with major depressive disorderdepressionJPRN-jRCT2031210577agata Tsutae400